{"id":29038,"date":"2015-10-01T12:07:35","date_gmt":"2015-10-01T12:07:35","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=29038"},"modified":"2015-10-21T08:12:16","modified_gmt":"2015-10-21T08:12:16","slug":"gilead-to-provide-free-hepatitis-drugs-to-treat-all-people-liviing-with-hepatitis-c-in-iceland","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/29038","title":{"rendered":"Gilead to provide free hepatitis drugs to treat all people liviing with hepatitis C in Iceland"},"content":{"rendered":"

Simon Collins, HIV i-Base<\/strong><\/p>\n

On 7 October, the Icelandic Ministry of Health announced that an agreement with Gilead Sciences would enable all people with hepatitis C in Iceland to receive free treatment with new direct acting antiviral (DAA) oral treatment.<\/strong><\/p>\n

This will initially involve at least 1200 people, but people who are diagnosed over the next few years will also have access to treatment<\/p>\n

In exchange, Gilead will use the results from the programme to study the potential for reducing HCV on a population level.<\/p>\n

Earlier this year a similar plan was announced to provide treatment to 25,000 people with hepatitis C in Georgia, which at 7% of the population has one of the highest prevalence rates for HCV (coming third after Egypt and Moldavia). [2]<\/p>\n

References:<\/p>\n

    \n
  1. Icelandic Ministry of Health. Efforts to eliminate hepatitis C in Iceland (7 October 2015).
    \nhttp:\/\/www.velferdarraduneyti.is\/frettir-vel\/nr\/35288<\/a>
    \n    https:\/\/translate.googleusercontent.com\/translate_c?depth=1&hl=en&prev=search&rurl=translate.google.co.uk&sl=is&u=http:\/\/www.velferdarraduneyti. is\/frettir-vel\/nr\/35288&usg=ALkJrhhhurQgh3_3ybHALM0561HDHWyP5Q<\/a><\/li>\n
  2. Hirschler B. Gilead uses Georgia as free-drug testbed for hepatitis C elimination. Reuters. (22 April 2015).
    \n    http:\/\/www.reuters.com\/article\/2015\/04\/22\/us-health-hepatitis-gilead-georgia-idUSKBN0ND1XU20150422<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Simon Collins, HIV i-Base On 7 October, the Icelandic Ministry of Health announced that an agreement with Gilead Sciences would enable all people with hepatitis C in Iceland to receive free treatment with new direct acting antiviral (DAA) oral treatment. …<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-29038","post","type-post","status-publish","format-standard","hentry","category-hepatitis-coinfection"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/29038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=29038"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/29038\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=29038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=29038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=29038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}